UK Markets open in 6 hrs 59 mins

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $6.4 Billion by 2027

·25-min read

Abstract: - Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $6. 4 Billion by 2027. - Amid the COVID-19 crisis, the global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.

New York, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Next Generation Sequencing (NGS) Sample Preparation Industry" - https://www.reportlinker.com/p06032338/?utm_source=GNW
3 Billion in the year 2020, is projected to reach a revised size of US$6.4 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Semi-Automated Library Preparation, one of the segments analyzed in the report, is projected to record a 10.7% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the NGS Library Preparation Kits segment is readjusted to a revised 9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $982.6 Million, While China is Forecast to Grow at 9.2% CAGR
- The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$982.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.
- Automated Library Preparation Segment to Record 10.2% CAGR
- In the global Automated Library Preparation segment, USA, Canada, Japan, China and Europe will drive the 10.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$508.6 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$736.7 Million by the year 2027.

- Select Competitors (Total 32 Featured) -

  • Agilent Technologies

  • Beckman Coulter (A Subsidiary of Danaher)

  • Becton, Dickinson and Company

  • Berry Genomics

  • BGI

  • F. Hoffmann-La Roche AG

  • Illumina, Inc.

  • Macrogen

  • New England Biolabs, Inc.

  • Novo Gene

  • Nugen Technologies, Inc.

  • Oxford Gene Technology

  • Oxford Nanopore Technologies

  • Pacific Biosciences of California, Inc.

  • Perkinelmer, Inc.

  • Qiagen N.V

  • Raindance Technologies, Inc.

  • Swift Biosciences Inc.

  • Thermo Fisher

  • WuXi AppTec




Read the full report: https://www.reportlinker.com/p06032338/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets for Years
2020 & 2027

Table 3: World Current & Future Analysis for Semi-Automated
Library Preparation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Semi-Automated Library
Preparation by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 5: World Current & Future Analysis for NGS Library
Preparation Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 6: World 7-Year Perspective for NGS Library Preparation
Kits by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Automated Library
Preparation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World 7-Year Perspective for Automated Library
Preparation by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Clonal
Amplification by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 10: World 7-Year Perspective for Clonal Amplification by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 11: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 12: World 7-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World 7-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 15: World Current & Future Analysis for Consumer Genomics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 16: World 7-Year Perspective for Consumer Genomics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 17: World Current & Future Analysis for Metagenomics,
Epidemiology & Drug Development by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 18: World 7-Year Perspective for Metagenomics,
Epidemiology & Drug Development by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World for Years 2020 &
2027

Table 19: World Current & Future Analysis for Agrigenomics &
Forensics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World 7-Year Perspective for Agrigenomics & Forensics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 21: World Current & Future Analysis for HLA Typing /
Immune System Monitoring by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 22: World 7-Year Perspective for HLA Typing / Immune
System Monitoring by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 23: World Current & Future Analysis for Academic Research
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 24: World 7-Year Perspective for Academic Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 25: World Current & Future Analysis for Clinical Research
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World 7-Year Perspective for Clinical Research by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 27: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 28: World 7-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 29: World Current & Future Analysis for Pharma & Biotech
Entities by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 30: World 7-Year Perspective for Pharma & Biotech
Entities by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 32: World 7-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 33: USA Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 34: USA 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by Workflow - Percentage Breakdown of
Value Sales for Semi-Automated Library Preparation, NGS Library
Preparation Kits, Automated Library Preparation and Clonal
Amplification for the Years 2020 & 2027

Table 35: USA Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 36: USA 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by Application - Percentage Breakdown
of Value Sales for Other Applications, Oncology, Consumer
Genomics, Metagenomics, Epidemiology & Drug Development,
Agrigenomics & Forensics and HLA Typing / Immune System
Monitoring for the Years 2020 & 2027

Table 37: USA Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 38: USA 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by End-Use - Percentage Breakdown of
Value Sales for Academic Research, Clinical Research, Hospitals &
Clinics, Pharma & Biotech Entities and Other End-Uses for the
Years 2020 & 2027

CANADA
Table 39: Canada Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 40: Canada 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 41: Canada Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 42: Canada 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 43: Canada Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 44: Canada 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

JAPAN
Table 45: Japan Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 46: Japan 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 47: Japan Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 48: Japan 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 49: Japan Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 50: Japan 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

CHINA
Table 51: China Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 52: China 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 53: China Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 54: China 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 55: China Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 56: China 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

EUROPE
Table 57: Europe Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 58: Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany, Italy,
UK and Rest of Europe Markets for Years 2020 & 2027

Table 59: Europe Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 60: Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 61: Europe Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 62: Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 63: Europe Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 64: Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

FRANCE
Table 65: France Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 66: France 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 67: France Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 68: France 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 69: France Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 70: France 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

GERMANY
Table 71: Germany Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 72: Germany 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 73: Germany Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Germany 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 75: Germany Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 76: Germany 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

ITALY
Table 77: Italy Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 78: Italy 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 79: Italy Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 80: Italy 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 81: Italy Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 82: Italy 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

UNITED KINGDOM
Table 83: UK Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 84: UK 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by Workflow - Percentage Breakdown of
Value Sales for Semi-Automated Library Preparation, NGS Library
Preparation Kits, Automated Library Preparation and Clonal
Amplification for the Years 2020 & 2027

Table 85: UK Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by Application - Other
Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 86: UK 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by Application - Percentage Breakdown
of Value Sales for Other Applications, Oncology, Consumer
Genomics, Metagenomics, Epidemiology & Drug Development,
Agrigenomics & Forensics and HLA Typing / Immune System
Monitoring for the Years 2020 & 2027

Table 87: UK Current & Future Analysis for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Academic
Research, Clinical Research, Hospitals & Clinics, Pharma &
Biotech Entities and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 88: UK 7-Year Perspective for Next Generation Sequencing
(NGS) Sample Preparation by End-Use - Percentage Breakdown of
Value Sales for Academic Research, Clinical Research, Hospitals &
Clinics, Pharma & Biotech Entities and Other End-Uses for the
Years 2020 & 2027

REST OF EUROPE
Table 89: Rest of Europe Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 90: Rest of Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 91: Rest of Europe Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Application -
Other Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 92: Rest of Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 93: Rest of Europe Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by End-Use -
Academic Research, Clinical Research, Hospitals & Clinics,
Pharma & Biotech Entities and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 94: Rest of Europe 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

ASIA-PACIFIC
Table 95: Asia-Pacific Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 96: Asia-Pacific 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 97: Asia-Pacific Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Application -
Other Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 98: Asia-Pacific 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 99: Asia-Pacific Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by End-Use -
Academic Research, Clinical Research, Hospitals & Clinics,
Pharma & Biotech Entities and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 100: Asia-Pacific 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by End-Use - Percentage
Breakdown of Value Sales for Academic Research, Clinical
Research, Hospitals & Clinics, Pharma & Biotech Entities and
Other End-Uses for the Years 2020 & 2027

REST OF WORLD
Table 101: Rest of World Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Workflow -
Semi-Automated Library Preparation, NGS Library Preparation
Kits, Automated Library Preparation and Clonal Amplification -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 102: Rest of World 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Workflow - Percentage
Breakdown of Value Sales for Semi-Automated Library
Preparation, NGS Library Preparation Kits, Automated Library
Preparation and Clonal Amplification for the Years 2020 & 2027

Table 103: Rest of World Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by Application -
Other Applications, Oncology, Consumer Genomics, Metagenomics,
Epidemiology & Drug Development, Agrigenomics & Forensics and
HLA Typing / Immune System Monitoring - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 104: Rest of World 7-Year Perspective for Next Generation
Sequencing (NGS) Sample Preparation by Application - Percentage
Breakdown of Value Sales for Other Applications, Oncology,
Consumer Genomics, Metagenomics, Epidemiology & Drug
Development, Agrigenomics & Forensics and HLA Typing / Immune
System Monitoring for the Years 2020 & 2027

Table 105: Rest of World Current & Future Analysis for Next
Generation Sequencing (NGS) Sample Preparation by End-Use -
Academic Research, Clinical Research, Hospitals & Clinics,
Pharma & Biotech Entities and Other End-Uses - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 106: Rest of World 7-Year Perspective for Next Generation

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032338/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting